Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2003
12/11/2003US20030229034 Drug delivery; nucleic acids; complexing
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer
12/11/2003US20030228618 Screening sample of nucleotide sequences for naturally occuring oligonucleotide associated with gene expression inhibition and modulation; drug screening; genetic mapping; tumor diagnosis
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228581 Comparing the nucleotide sequence encoding the AIF protein from a human biopsy to a wild-type
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228568 Inducible phosphofructokinase and the warburg effect
12/11/2003US20030228329 Genetic engineering; insertion of gene; generating immunology response
12/11/2003US20030228327 Mixture of plasmids, protein which induce immunology response; Aids therapy
12/11/2003US20030228295 Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
12/11/2003US20030228293 Correction of genetic defects
12/11/2003US20030228292 Methods of inducing or enhancing connective tissue repair
12/11/2003US20030228291 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy
12/11/2003US20030228284 Secretion signal vectors
12/11/2003US20030228283 Preventing secondary lymphedema with VEGF-D DNA
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003US20030228281 Use of mutant herpes viruses and anticancer agents in the treatment of cancer
12/11/2003US20030228280 System for production of helper dependent adenovirus vectors based on use of endonucleases
12/11/2003CA2736974A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736972A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
12/11/2003CA2736921A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003CA2488270A1 Paramyxoviral vectors encoding antibodies, and uses thereof
12/11/2003CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003CA2488013A1 Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
12/11/2003CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003CA2487928A1 Pthrp-based prediction and diagnosis of bone disease
12/11/2003CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003CA2487724A1 Immunogenic sequences
12/11/2003CA2487427A1 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
12/11/2003CA2487410A1 Intramyocardial injection of autologous bone marrow
12/11/2003CA2487304A1 Materials and methods relating to polyions and substance delivery
12/11/2003CA2487137A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/11/2003CA2486658A1 Method for efficient rna interference in mammalian cells
12/10/2003EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/10/2003EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy
12/10/2003EP1369479A1 Novel cell adhesion molecule specific to activated leukocyte
12/10/2003EP1369133A1 Gene carriers with the use of polysaccharide and process for producing the same
12/10/2003EP1368656A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368375A2 Secretory molecules
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368039A2 Aminoglycoside treatment for lysosomal storage diseases
12/10/2003EP1368036A1 Regulation of glucocorticoid concentration
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1017365B1 Liposome-entrapped polynucleotide composition and method
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/10/2003EP0771146B1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
12/10/2003EP0679191B1 Detection and treatment of mutations in a cd40 ligand gene
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0651759B1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
12/10/2003CN1461343A 多核苷酸 Polynucleotide
12/10/2003CN1461340A Method of isolating bipotent hepatic progenitor cells
12/10/2003CN1130221C Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
12/09/2003US6660906 Tpl2 transgenic knockout mice
12/09/2003US6660845 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
12/09/2003US6660840 Ability to stimulate a Th1 response in peripheral blood mononuclear cells; contain a biologically active portion of a Leishmania braziliensis
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660715 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
12/09/2003US6660521 Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus
12/09/2003US6660520 Nrde
12/09/2003US6660275 Amplification nucleic acids
12/09/2003US6660272 For protection against Porcine Multisystemic Wasting Syndrome also called Post- weaning Multisystemic Wasting Syndrome
12/09/2003US6660270 Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection
12/09/2003US6660260 Bioprosthetic heart valves
12/09/2003US6660257 Flt-3 receptor agonist proteins; nucleic acid sequence
12/09/2003CA1341449C Poly-kringle plasminogen activator
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100436A2 Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (ccr10)
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100099A1 Parallel stranded duplexes of deoxyribonucleic acid and methods of use
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100081A2 Biologically active maleamic acid derivatives with labile amide bonds
12/04/2003WO2003100070A2 The frog prince, a transposon vector for gene transfer in vertebrates
12/04/2003WO2003100060A2 Muc-1 antigen with reduced number of vntr repeat units
12/04/2003WO2003100053A1 Compositions and methods for the treatment of hemophilia a
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003100031A2 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
12/04/2003WO2003100006A2 Method of improved prostate cancer detection
12/04/2003WO2003099997A2 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003WO2003099991A2 Glp-1 gene delivery for the treatment of type 2 diabetes
12/04/2003WO2003099864A1 Use of monocarboxylate transporter protein for thyroid hormone transport
12/04/2003WO2003099861A1 Use of a pestivirus ns3-like protein for inducing cell apoptosis
12/04/2003WO2003099859A2 Novel use of adenoviruses and nucleic acids coding therefor
12/04/2003WO2003099850A2 Mutant p53 (δ126-132) protein and uses thereof
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 870